StonvexLoading…
StonvexStonvexStonvexCore line items from ELSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.14M | $9.37M | $8.55M | $9.03M |
Operating Income | $2.00K | $-4.00K | $-28.00K | $-37.00K |
Net Income | $306.00K | $446.00K | $275.00K | $100.00K |
EPS (Diluted) | $0.09 | $0.13 | $0.08 | $0.03 |
Total Assets | $15.70M | $14.88M | $14.45M | $14.04M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.54M | $9.95M | $9.87M | $7.65M |
Free Cash Flow OCF − CapEx | $597.00K | $78.00K | $251.00K | $-212.00K |
Shares Outstanding | 3.48M | 3.45M | 3.43M | 3.43M |